Sandra Castaño-Díez

14PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classifiedMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|Jan 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC).

Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo

|Jan 08, 2025
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

Alexandra Martínez-Roca, Carlos Jiménez-Vicente, Beatriz Merchán

|Oct 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular.

Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti

|Sep 30, 2024
Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia?

Sandra Castaño-Díez, José Ramón Álamo, Mònica López-Guerra

|Aug 29, 2024
Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Francesca Guijarro, Sandra Castaño-Díez, Carlos Jiménez-Vicente

Pageof 3

Frequent Collaborators

8 joint publications

Francesca Guijarro

5 joint publications

Jordi Esteve

5 joint publications

José Ramón Álamo Moreno

5 joint publications

Carlos Jiménez-Vicente